deferoxamine has been researched along with hydroxyindoleacetic acid in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Buchle, AM; Steulet, AF; Waldmeier, PC | 1 |
1 other study(ies) available for deferoxamine and hydroxyindoleacetic acid
Article | Year |
---|---|
Inhibition of catechol-O-methyltransferase (COMT) as well as tyrosine and tryptophan hydroxylase by the orally active iron chelator, 1,2-dimethyl-3-hydroxypyridin-4-one (L1, CP20), in rat brain in vivo.
Topics: Administration, Oral; Animals; Catechol O-Methyltransferase Inhibitors; Corpus Striatum; Deferiprone; Deferoxamine; Dopamine; Female; Hydroxyindoleacetic Acid; Iron Chelating Agents; Male; Pyridones; Rats; Serotonin; Tryptophan Hydroxylase; Tyrosine; Tyrosine 3-Monooxygenase | 1993 |